AI assistant
Sending…
FEDEX CORP — Director's Dealing 2022
Sep 7, 2022
29990_dirs_2022-09-07_439ffeb3-2e15-4f17-8c35-c2f4b0c44205.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FEDEX CORP (FDX)
CIK: 0001048911
Period of Report: 2022-09-01
Reporting Person: Smith Richard W (President/CEO FedEx Express)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 78294 | Direct |
| Common Stock | 59296 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $96.865 | 2023-06-03 | Common Stock (1300) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $143.545 | 2024-06-09 | Common Stock (3875) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $180.82 | 2025-06-08 | Common Stock (3220) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $162.82 | 2026-06-06 | Common Stock (3805) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $207.305 | 2027-06-12 | Common Stock (4900) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $214.00 | 2027-07-17 | Common Stock (145) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $261.78 | 2028-06-11 | Common Stock (5250) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $161.85 | 2029-06-10 | Common Stock (10635) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $147.28 | 2029-09-23 | Common Stock (5900) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $130.96 | 2030-06-15 | Common Stock (18000) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $294.605 | 2031-06-14 | Common Stock (6605) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $226.945 | 2032-06-30 | Common Stock (18040) | Direct |
Footnotes
F1: These options vest ratably over four years from the date of grant and are first exercisable one year from date of grant.
More from FEDEX CORP
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 22
Board/Management Information
2026
May 18
Board/Management Information
2026
Apr 13
Director's Dealing
2026
Mar 23
Interim / Quarterly Report
2026
Mar 19
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 20
M&A Activity
2026
Feb 9
Capital/Financing Update
2026
Feb 5